| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment. |
| 掲載誌名 | 正式名:Annals of oncology |
| 掲載区分 | 国外 |
| 巻・号・頁 | 28(7),pp.1532-1539 |
| 著者・共著者 | Haratani K, Hayashi H, Tanaka T, Kaneda H, Togashi Y, Sakai K, Hayashi K, Tomida S, Chiba Y, Yonesaka K, Nonagase Y, Takahama T, Tanizaki J, Tanaka K, Yoshida T, Tanimura K, Takeda M, Yoshioka H, Ishida T, Mitsudomi T, Nishio K, Nakagawa K. |
| 発行年月 | 2017/07 |
| DOI | 10.1093/annonc/mdx183 |
| PMID | 28407039 |